Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

XCath Robotics Receives FDA Breakthrough Device Designation for the Iris System ...

10 September 2026 · By · Wire by Fusion42

Published

10 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at streetinsider.com →

◆ Verified

Fusion42 · 11 September 2026 · Fusion42 review

XCath Robotics has received FDA Breakthrough Device Designation for its Iris System, a remote robotic-assisted mechanical thrombectomy device intended to treat acute ischemic stroke.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

FDA’s breakthrough designation opens a fast-track route for your stroke treatment device, speeding market entry and investor interest. You must now accelerate clinical validation and prepare to scale regulatory engagement.

◆ Coverage

1 source · 10 Sep 2026

◆ Related on Wire

◆ Topics

MedtechFDA-approvalrobotic-surgeryacute-strokemedical-devices